NCT06271005

Neurological Dry Eye Study Stimulating Both Lacrimal and Vagus Nerves

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 75 (estimated)
• Sponsor: Genetic Disease Investigators · Academic / Other
• Sex: All
• Age: 20 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This is a study on neurological dry eye disease, focusing on a patented over-the-counter supplement supporting tear production neurologically, including the lacrimal and vagus nerves.

Detailed description

Chronic inflammation is implicated in the majority of chronic dry eyes. The parasympathetic nervous system is responsible for both basal tear secretion (the aqueous layer) by the lacrimal functional unit, and is responsible for controlling many aspects of chronic inflammation via the vagus nerve. This study will document its effects on dry eyes, in addition to other symptoms/signs of low parasympathetic nervous system functioning using an over-the-counter supplement.

Conditions

• Dry Eye Disease
• Dry Eye

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	NeuroTears	Over-the-counter supplement
DIETARY_SUPPLEMENT	Placebo	Oral placebo pill

Timeline

• Start date: 2024-04-01
• Primary completion: 2024-10-01
• Completion: 2024-10-01
• First posted: 2024-02-21
• Last updated: 2024-02-21